n.抗凝血酶

Antithrombin is a vital protein in the bloodstream that helps prevent blood clots.
抗凝血酶是血液中的一种重要蛋白质，有助于防止血栓形成。
The deficiency of antithrombin increases the risk of thrombotic events in patients with hereditary thrombophilia.
对抗凝血酶的缺乏会增加遗传性血栓病患者发生血栓事件的风险。
Doctors administer heparin to temporarily inhibit antithrombin, allowing for safe surgical procedures.
医生在手术期间使用肝素暂时抑制抗凝血酶，以确保手术安全进行。
Monitoring levels of antithrombin is crucial in managing patients on warfarin, an anticoagulant drug.
监测抗凝血酶水平对于管理华法林（抗凝药物）患者至关重要。
Antithrombin III therapy has shown promise in reducing the recurrence of deep vein thrombosis (DVT) in high-risk patients.
抗凝血酶III疗法在降低高危患者深静脉血栓（DVT）复发方面显示出前景。
Hemophilia patients often require regular infusions of antithrombin to compensate for their deficiency in natural anticoagulation factors.
血友病患者常常需要定期注射抗凝血酶来弥补他们体内自然抗凝因子的不足。
Antithrombin deficiency can lead to an increased risk of thrombosis, necessitating close medical supervision and treatment adjustments.
抗凝血酶缺乏可能导致血栓风险增加，需要密切的医疗监控和治疗调整。
The ratio of antithrombin to thrombin is crucial for maintaining proper blood clotting and preventing excessive bleeding.
抗凝血酶与凝血酶的比例对保持适当的血凝和防止出血过多至关重要。
Researchers are investigating novel drugs that target antithrombin as a potential strategy to combat thromboembolic disorders.
研究人员正在研究针对抗凝血酶的新药，作为对抗血栓栓塞性疾病的潜在策略。
Inherited disorders affecting antithrombin can manifest as a bleeding disorder, highlighting the importance of genetic testing in family planning.
影响抗凝血酶的遗传疾病可能会表现为出血性疾病，这突显了遗传检测在家庭规划中的重要性。